GSK workers may be in trouble with UK authorities; EU pledges €550M to fight AIDS, tuberculosis and malaria
→ A contingent of GSK $GSK employees might be in trouble with the UK tax authorities. On Sunday, the Financial Times reported that HM Revenue & Customs accused nearly 1,500 of GSK’s contractors of being “disguised employees” in identical letters to workers in the IT and biomedical sciences divisions at the British drugmaker. The workers have been filing their tax returns as self-employed individuals, HMRC alleged in the letters. “Whether a worker is employed or self-employed for tax purposes is not a matter of choice. Instead, you need to look at the facts of the working relationship between you and GSK,” the report noted, citing the letters.
→ On Saturday, the EU pledged €550 million to the Global Fund to fight AIDS, tuberculosis and malaria during the G-7 summit. Since its creation in 2002, the EC has contributed more than €2.6 billion to the fund.
→ After poaching Alnylam $ALNY executive Emmanuel Dulac to take over the reins as CEO at Zealand Pharma $ZEAL earlier this year, the Copenhagen-based biotech is relocating to its new headquarters located in Søborg, approximately 12 kilometers from its current facilities. The move is designed to accommodate Zealand’s workforce growth, as well as the longer-term strategic initiative for introducing commercial support, it said on Tuesday.